From: SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma
Variables | n | Univariable Analysis | Â | Multivariable Analysis | |
---|---|---|---|---|---|
HR (95% CI) | P Value a | HR (95% CI) | P Value a | ||
Gender | Â | Â | Â | Â | Â |
 Male | 14 | 1 |  |  |  |
 Female | 84 | 0.618(0.308-1.240) | 0.176 |  | n.a. |
Age (years) | Â | Â | Â | Â | Â |
 >60 | 27 | 1 |  |  |  |
 ≤60 | 71 | 0.589(0.342-1.011) | 0.055 |  | n.a. |
Hepatitis B status | Â | Â | Â | Â | Â |
 Negative | 17 | 1 |  |  |  |
 Positive | 81 | 0.649(0.367-1.145) | 0.135 |  | n.a. |
AFP(ng/ml) | Â | Â | Â | Â | Â |
 ≥20 | 70 | 1 |  |  |  |
 <20 | 28 | 0.719(0.448-1.156) | 0.173 |  | n.a. |
Liver cirrhosis | Â | Â | Â | Â | Â |
 Absent | 17 | 1 |  |  |  |
 Present | 81 | 0.662(0.369-1.188) | 0.167 |  | n.a. |
Tumor size (cm) | Â | Â | Â | Â | Â |
 ≤3 | 36 | 1 |  | 1 |  |
 > 3 | 62 | 1.901(1.175-3.074) | 0.009 | 1.663(0.921-3.004) | 0.092. |
Number of tumors | Â | Â | Â | Â | Â |
 Single | 47 | 1 |  | 1 |  |
 Multiple (≥ 2) | 51 | 1.677 (1.059-2.656) | 0.027 | 0.629(0.337-1.176) | 0.147 |
Vascular invasion | Â | Â | Â | Â | Â |
 Absent | 45 | 1 |  | 1 |  |
 Present | 53 | 2.633(1.625-4.268) | <0.001 | 2.023(1.679-2.998) | 0.031 |
Child-Pugh classification | Â | Â | Â | Â | Â |
 A | 76 | 1 |  |  |  |
 B | 22 | 1.130 (0.640-1.993) | 0.674 |  | n.a. |
Edmondson-Steiner grade | Â | Â | Â | Â | Â |
 I-II | 72 | 1 |  |  |  |
 III-IV | 26 | 1.138 (0.692-1.872) | 0.611 |  | n.a. |
TNM stage | Â | Â | Â | Â | Â |
 I/ II | 49 | 1 |  | 1 |  |
 III | 49 | 1.882(1.440-2.461) | <0.001 | 1.953(1.163-3.279) | 0.011 |
BCLC | Â | Â | Â | Â | Â |
 0-A | 54 | 1 |  | 1 |  |
 B/C | 44 | 1.776(1.386-2.277) | <0.001 | 0.941(0.589-1.503) | 0.799 |
SYNJ2BP expression | Â | Â | Â | Â | Â |
 Low | 39 | 1 |  | 1 |  |
 High | 59 | 0.306(0.186-0.506) | <0.001 | 0.461(0.230-0.927) | 0.030 |